Literature DB >> 12402265

Thalamic neurodegeneration in multiple sclerosis.

Alberto Cifelli1, Marzena Arridge, Peter Jezzard, Margaret M Esiri, Jacqueline Palace, Paul M Matthews.   

Abstract

Multiple sclerosis is still regarded primarily as a disease of the white matter. However, recent evidence suggests that there may be significant involvement of gray matter. Here, we have used magnetic resonance imaging and magnetic resonance spectroscopy in vivo and histopathology postmortem to estimate thalamic neuronal loss in patients with multiple sclerosis. Our results show that neuronal loss in multiple sclerosis can be substantial (30-35% reduction). We conclude that a neurodegenerative pathology may make a major contribution to the genesis of symptoms in multiple sclerosis.

Entities:  

Mesh:

Year:  2002        PMID: 12402265     DOI: 10.1002/ana.10326

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  127 in total

1.  Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation.

Authors:  Jitendra Sharma; Michael P Sanfilipo; Ralph H B Benedict; Bianca Weinstock-Guttman; Frederick E Munschauer; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

Review 2.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

3.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Authors:  Robert A Bermel; Srinivas R Puli; Richard A Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E Munschauer; Rohit Bakshi
Journal:  Arch Neurol       Date:  2005-09

4.  Interhemispheric asymmetry of brain diffusivity in normal individuals: a diffusion-weighted MR imaging study.

Authors:  Andrew J Fabiano; Mark A Horsfield; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

Review 5.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 6.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

7.  New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.

Authors:  Tim Sinnecker; Esther Ruberte; Sabine Schädelin; Vera Canova; Michael Amann; Yvonne Naegelin; Iris-Katharina Penner; Jannis Müller; Jens Kuhle; Bernhard Décard; Tobias Derfuss; Ludwig Kappos; Cristina Granziera; Jens Wuerfel; Stefano Magon; Özgür Yaldizli
Journal:  J Neurol       Date:  2019-10-14       Impact factor: 4.849

8.  A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.

Authors:  Antonia Ceccarelli; Maria A Rocca; Paola Valsasina; Mariaemma Rodegher; Elisabetta Pagani; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

9.  Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.

Authors:  Kedar R Mahajan; Kunio Nakamura; Jeffrey A Cohen; Bruce D Trapp; Daniel Ontaneda
Journal:  Ann Neurol       Date:  2020-05-01       Impact factor: 10.422

10.  Relevance of the skewness index in DTI exploration of multiple sclerosis.

Authors:  Eliane Graulières; Jean-Albert Lotterie; Emmanuelle Cassol; Angélique Gerdelat; Michel Clanet; Isabelle Berry
Journal:  MAGMA       Date:  2008-11-08       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.